AFMD is an indication of anything, it is of third- rate ADXS management. ADXS, which was supposed to be a leader in LM based immunotherapy has a MC of $75 million while AFMD, which no one had heard of until two days ago has an MC of close to $300 million.
Is AFMD an indication of anything to do with ADXS, given the BOD and management?